R01 CA187273/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2014	1
2015	1
2016	2
2017	3
2018	1
2019	1
2023	1
2024	0

1

Bis(N-amidinohydrazones) and N-(amidino)-N'-aryl-bishydrazones: New classes of antibacterial/antifungal agents.

Shrestha SK, Kril LM, Green KD, Kwiatkowski S, Sviripa VM, Nickell JR, Dwoskin LP, Watt DS, Garneau-Tsodikova S. Shrestha SK, et al. Bioorg Med Chem. 2017 Jan 1;25(1):58-66. doi: 10.1016/j.bmc.2016.10.009. Epub 2016 Oct 10. Bioorg Med Chem. 2017. PMID: 27769670 Free PMC article.

2

GRP78 Is a Targetable Receptor on Cancer and Stromal Cells.

Araujo N, Hebbar N, Rangnekar VM. Araujo N, et al. EBioMedicine. 2018 Jul;33:2-3. doi: 10.1016/j.ebiom.2018.06.030. Epub 2018 Jul 8. EBioMedicine. 2018. PMID: 29997052 Free PMC article. No abstract available.

3

Par-4 secretion: stoichiometry of 3-arylquinoline binding to vimentin.

Sviripa VM, Burikhanov R, Obiero JM, Yuan Y, Nickell JR, Dwoskin LP, Zhan CG, Liu C, Tsodikov OV, Rangnekar VM, Watt DS. Sviripa VM, et al. Org Biomol Chem. 2016 Jan 7;14(1):74-84. doi: 10.1039/c5ob01980j. Org Biomol Chem. 2016. PMID: 26548370 Free PMC article.

4

A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.

Hebbar N, Burikhanov R, Shukla N, Qiu S, Zhao Y, Elenitoba-Johnson KSJ, Rangnekar VM. Hebbar N, et al. Cancer Res. 2017 Aug 1;77(15):4039-4050. doi: 10.1158/0008-5472.CAN-16-1970. Epub 2017 Jun 16. Cancer Res. 2017. PMID: 28625975 Free PMC article.

5

Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition.

Burikhanov R, Ganguly S, Ellingson S, Sviripa VM, Araujo N, Li S, Venkatraman P, Rao M, Choughule A, Brainson CF, Zhan CG, Spielmann HP, Watt DS, Govindan R, Rangnekar VM. Burikhanov R, et al. Am J Cancer Res. 2023 Mar 15;13(3):976-991. eCollection 2023. Am J Cancer Res. 2023. PMID: 37034206 Free PMC article.

6

Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells.

Sarkar S, Jain S, Rai V, Sahoo DK, Raha S, Suklabaidya S, Senapati S, Rangnekar VM, Maiti IB, Dey N. Sarkar S, et al. Front Plant Sci. 2015 Oct 7;6:822. doi: 10.3389/fpls.2015.00822. eCollection 2015. Front Plant Sci. 2015. PMID: 26500666 Free PMC article.

7

Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer.

Kim K, Araujo P, Hebbar N, Zhou Z, Zheng X, Zheng F, Rangnekar VM, Zhan CG. Kim K, et al. Protein Eng Des Sel. 2019 Dec 13;32(3):159-166. doi: 10.1093/protein/gzz034. Protein Eng Des Sel. 2019. PMID: 31711233 Free PMC article.

8

Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis.

Burikhanov R, Hebbar N, Noothi SK, Shukla N, Sledziona J, Araujo N, Kudrimoti M, Wang QJ, Watt DS, Welch DR, Maranchie J, Harada A, Rangnekar VM. Burikhanov R, et al. Cell Rep. 2017 Jan 10;18(2):508-519. doi: 10.1016/j.celrep.2016.12.051. Cell Rep. 2017. PMID: 28076793 Free PMC article.

9

Arylquins target vimentin to trigger Par-4 secretion for tumor cell apoptosis.

Burikhanov R, Sviripa VM, Hebbar N, Zhang W, Layton WJ, Hamza A, Zhan CG, Watt DS, Liu C, Rangnekar VM. Burikhanov R, et al. Nat Chem Biol. 2014 Nov;10(11):924-926. doi: 10.1038/nchembio.1631. Epub 2014 Sep 14. Nat Chem Biol. 2014. PMID: 25218743 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year